drugset / Trial / NCT04948099
A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases
RandomizedParallel-groupTriple-blindTreatment
Summary
A first-in-human study to evaluate the safety and tolerability of escalating, single and multiple ascending doses of VIB1116 in adult participants with rheumatic diseases.
Timeline
- Start
- 2021-07-06
- Primary completion
- 2023-07-03
- Completion
- 2023-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VIB1116 | Unknown | — | Subcutaneous |
Indications
No indication recorded.